Article
The Intricate Metabolism of Pancreatic Cancers.
Advances in experimental medicine and biology - 1 Jan 2021
Camelo Felipe, Le Anne
Abstract excerpt
Currently, approximately 95% of pancreatic cancers are pancreatic ductal adenocarcinomas (PDAC), which are the most aggressive form and the fourth leading cause of cancer death with extremely poor prognosis [1]. Poor prognosis is primarily attributed to the late diagnosis of the disease when patients are no longer candidates for surgical resection [2]. Cancer cells are dependent on the oncogenes that allow them...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
